Callum Talbot-Cooper

Callum Talbot-Cooper has a diverse work experience in the field of scientific research. Callum is currently working as a Scientist at bit.bio since January 2023. Prior to this, they worked as a Research Scientist at Cell Guidance Systems from February 2022 to January 2023.

Callum's academic background includes a PHD at the University of Cambridge, where they served as a PHD Student in the Department of Pathology from October 2016 to December 2021. Their research focused on host-pathogen interactions, particularly investigating how viruses suppress the host immune response. Their work has led to the discovery of a novel poxvirus inhibitor of interferon-induced signaling.

In 2020, Callum undertook a PhD Internship at ELIXIR, where they worked with the external relationship team. During this time, they wrote science news articles, led a project to develop COVID-19 bioinformatic workflows, and contributed to a larger ELIXIR project assessing the impact of open resource data for biotech companies.

Additionally, Callum gained experience as a Microbiologist at CENTRE FOR RESEARCH INTO ENVIRONMENT AND HEALTH (CREH) LTD in 2016, where they analyzed water samples for bacterial content. Callum also worked as a Dean's summer research scholar at the University of Leeds in 2015.

Callum Talbot-Cooper completed their Bachelor of Science degree in Microbiology from the University of Leeds in the years 2013 to 2016. After that, they pursued further education and obtained their Doctor of Philosophy (PhD) degree in Virology and cell signalling from the University of Cambridge between 2016 and 2022.